Insider Buying Sees Notable Moves in BHRB and TLSI Stocks

Insider Buying Alert: Recent transactions by key executives at BHRB and TLSI suggest confidence in future performance, potentially influencing stock prices positively.

Date: 30-01-2025

AI Rating: 7

**Insider Buying Activity** shows strong confidence from key executives in Burke Herbert Financial Services (BHRB) and TriSalus Life Sciences (TLSI). On Wednesday, BHRB's Director, Shawn Patrick McLaughlin, purchased 1,000 shares at $63.00, resulting in a 2.9% gain at one point during trading. His prior investments show a total cost of $275,081 at an average of $57.91 per share over the past year, indicating a bullish stance.

Simultaneously, CEO Mary T. Szela of TriSalus Life Sciences bought 9,542 shares at $5.27 each, totaling $50,303. Her earlier investments totaled $100,209 at an average price of $5.06 per share, reaffirming her positive outlook. Furthermore, TLSI saw a substantial increase of 6.8% on Thursday. This insider buying could reflect strong future prospects for both companies, making them potentially attractive investments for shareholders.

Stocks: BHRB TLSI